FINANCIALS

TNGX Tango Therapeutics Inc 1819133

Income Statement
Revenue	tngx-20241231	42,069,000
Net Income	tngx-20241231	-130,302,000
Profit Margin		-309.73%

Balance Sheet
Current Assets	266,343,000
Assets	316,492,000
Current Liabilities	38,170,000
Liabilities	116,975,000
Equity	199,517,000
Shares Out	142,689,000

Cash Flow Statement
Operating Cash Flow	-131,501,000
Investing Cash Flow	86,126,000

Market Analysis
Market Cap	3,885,884,945
Price	26.94
BVPS	1.86
PB	0.92
EPS	-0.87
PS	5.48
FCF	-45,375,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view TNGX documents filed with the SEC.

TNGX Filings Clear

View A List of Tickers